Details for New Drug Application (NDA): 202799
✉ Email this page to a colleague
NDA 202799 describes OMONTYS PRESERVATIVE FREE, which is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are six patents protecting this drug. Additional details are available on the OMONTYS PRESERVATIVE FREE profile page.
The generic ingredient in OMONTYS PRESERVATIVE FREE is peginesatide acetate. Additional details are available on the peginesatide acetate profile page.
The generic ingredient in OMONTYS PRESERVATIVE FREE is peginesatide acetate. Additional details are available on the peginesatide acetate profile page.
Summary for 202799
| Tradename: | OMONTYS PRESERVATIVE FREE |
| Applicant: | Takeda Pharms Usa |
| Ingredient: | peginesatide acetate |
| Patents: | 6 |
| Formulation / Manufacturing: | see details |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | Strength | EQ 1MG BASE/0.5ML (EQ 1MG BASE/0.5ML) | ||||
| Approval Date: | Mar 27, 2012 | TE: | RLD: | No | |||||
| Patent: | ⤷ Try a Trial | Patent Expiration: | May 12, 2024 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
| Patented Use: | TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE | ||||||||
| Patent: | ⤷ Try a Trial | Patent Expiration: | May 12, 2024 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
| Patented Use: | TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE | ||||||||
| Patent: | ⤷ Try a Trial | Patent Expiration: | May 12, 2024 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Expired US Patents for NDA 202799
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | OMONTYS PRESERVATIVE FREE | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-005 | Mar 27, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
| Takeda Pharms Usa | OMONTYS | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-008 | Mar 27, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
| Takeda Pharms Usa | OMONTYS | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-007 | Mar 27, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
| Takeda Pharms Usa | OMONTYS | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-008 | Mar 27, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
| Takeda Pharms Usa | OMONTYS | peginesatide acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799-008 | Mar 27, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
